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0022-2836/$ - see front matter © 2008 EMany Gram-negative pathogenic bacteria use a complex macromolecular
machine, known as the type 3 secretion system (T3SS), to transfer virulence
proteins into host cells. The T3SS is composed of a cytoplasmic bulb, a basal
body spanning the inner and outer bacterial membranes, and an extra-
cellular needle. Secretion is regulated by both cytoplasmic and inner mem-
brane proteins that must respond to specific signals in order to ensure that
virulence proteins are not secreted before contact with a eukaryotic cell. This
negative regulation is mediated, in part, by a family of proteins that are
thought to physically block the entrance to the secretion apparatus until an
appropriate signal is received following host cell contact. Despite weak
sequence homology between proteins of this family, the crystal structures of
Shigella flexneri MxiC we present here confirm the conservation of domain
topology with the homologue from Yersinia sp. Interestingly, comparison of
the Shigella and Yersinia structures reveals a significant structural change
that results in substantial domain re-arrangement and opening of one face
of the molecule. The conservation of a negatively charged patch on this face
suggests it may have a role in binding other components of the T3SS.© 2008 Elsevier Ltd. All rights reserved.Keywords: type 3 secretion system; Shigella flexneri; MxiC; secretion
regulation; YopNEdited by I. WilsonShigella flexneri is a Gram-negative bacterial patho-
gen that causes human bacillary dysentery resulting
in over a million deaths annually worldwide. The
pathogenicity of Shigella sp. is dependent on a com-
plex macromolecular machine, the type 3 secretion
system (T3SS), that delivers into host cells a set of
effector proteins required for invasion. The Shigella
sp. T3SS consists of structural components of the
injection machinery, secreted proteins, chaperones
and regulators, all of which are encoded by approx-
imately 25 genes located in the mxi, spa and ipa
operons on a large 230 kb plasmid.1–3ess:
ecretion system; Mxi,
smid antigens; Yop,
lsevier Ltd. All rights reserveThe delivery of effectors into host cells involves
secretion, the crossing of both bacterial membranes
via the basal body, and translocation, the passage
through the eukaryotic cell membrane. Following
assembly of the external needle, the proteins secreted
via the T3SS fall into two main categories: translo-
cators and effectors. Upon host cell contact, translo-
cators assemble into the host cell membrane, forming
a pore complex, or translocon, that triggers the sub-
sequent export of effectors.4 Since translocators must
be secreted before effectors, so that effectors will be
exported directly into host cells instead of the extra-
cellular milieu, pathogens require mechanisms to
ensure hierarchical and temporal control over their
secretion. Although the exact mechanisms under-
lying these processes are not clearly established,
several cytoplasmic and inner-membrane proteins
have been identified that recognize secretion sub-
strates and respond to specific signals to ensure that
structural and sensing components (needle subunitsd.
Fig. 1. Size-exclusion chromatography and limited
proteolysis of MxiC. a, Elution of MxiCFL (continuous
line) and MxiCNΔ73 (broken line) from a HiLoad 16/60
Superdex 200 column pre-equilibrated in 20 mM Tris
(pH 7.5), 150 mM NaCl. MxiCFL and MxiCNΔ73 elute as
monomers as single, slightly asymmetric peaks. b, SDS-
PAGE of limited proteolysis of MxiCFL. Degradation of
purified MxiCFL was considerable after storage at 4 °C for
eight weeks (lane 1). Limited proteolysis was carried out on
freshly purified MxiCFL incubated for 2 h at 20 °C with an
increasingmass ratio of protein:subtilisin from 20 μg:2 ng to
20 μg:80 ng (lanes 2–6). Methods: DNA fragments of the
mxiC gene encoding residues 1–355 (full length, MxiCFL)
and 74–355 (N-terminal truncation, MxiCNΔ73) were
produced by PCR (FLf, CATATGCTTGATGTTAAAAATA-
CAGGAGTTTTT; N73f, CATATGAGTCAGGAACGTATT-
TTAGAT; FLr, GAATTCTTATCTAGAAAGCTCTTTCTTG-
TATGCACT) and cloned into the NdeI-EcoRI sites of the
pET28b vector. These constructs include an N-terminal
His6-tag and a thrombin cleavage site. MxiC constructs
were expressed in Escherichia coli BL21 (DE3) cells grown in
LB medium containing 34 μg ml−1 kanamycin. Cells were
grown at 37 °C until an A600 nm of ∼0.6 was reached,
whereupon they were cooled to 20 °C and protein over-
expression was induced by the addition of IPTG (1.0 mM
final concentration). After ∼16 h, cells were harvested by
centrifugation (15 min, 5000g, 4 °C) and pellets were frozen
at –80 °C. Cell pellets were resuspended in lysis buffer
(20 mM Tris (pH 7.5), 500 mM NaCl and Complete
EDTA-free Protease Inhibitor Cocktail, Roche) and lysed
using an Emulsiflex-C5 Homogeniser (Glen Creston, UK).
The resultant cell suspension was centrifuged (20 min,
20,000g, 4 °C) and the soluble fraction was applied to a pre-
charged HisTrap FF nickel affinity column (GE Life
Sciences). Protein was eluted using a gradient of 0–1 M
imidazole in 20 mM Tris (pH 7.5), 500 mM NaCl and
986 MxiC Structures Differ from the Yersinia Homologueand pore proteins) are secreted first, and that
virulence proteins are not secreted before contact
with a host cell.
Blockage of effector secretion before host cell
contact is mediated, in part, by a protein that has
been proposed to act as either a physical impediment
to the entrance to the secretion apparatus,5 or as a
gatekeeper that determines substrate hierarchy.6
Across bacterial species, this protein (known as
MxiC in Shigella sp.) possesses only weak sequence
homology and in some species exists as two separate
polypeptide chains (e.g., in Yersinia sp. the homo-
logue consists of YopN and TyeA).7 Despite this,
distinct functional homologies can be identified
across species. Functional knock-outs of members
of this family have no effect on needle formation or
stability but significantly reduce or abolish the secre-
tion of translocators.8–11 In addition, in several spe-
cies thesemutations also result in enhanced secretion
of effector proteins.9–14 This differential effect on
translocator and effector secretion suggests that
these proteins have a role in T3SS discrimination
between secreted proteins involved in translocation
and proteins that have effector function.
There are, however, several differences between
the members of this family. Most notably, activation
of type 3 secretion in Yersinia sp. results in the sec-
retion of YopN, while TyeA remains in the bacterial
cytoplasm.15,16 The dissociation of YopN and TyeA
has been proposed as a mechanism for the regula-
tion of secretion but clearly cannot be a conserved
mechanism in those species where the homologue is
a single polypeptide chain.17 In the crystal structure
of the Y. pestis YopN-TyeA complex, the close
proximity of the C terminus of YopN with the N
terminus of TyeA suggested that a single polypep-
tide encoding both proteins could maintain the same
overall structure.5 In order to confirm this, we have
determined and refined the structure of the S.
flexneri homologue, MxiC, in three distinct crystal
forms. The molecular architecture and movement of
the domains of MxiC compared with that of YopN-
TyeA highlights conformational differences that
may play an important role in T3SS signaling.Proteolytic susceptibility of the N terminus of
MxiC
A full-length construct of MxiC (residues 1–355,
MxiCFL) was purified by nickel-affinity chromato-
graphy followed by size-exclusion chromatography
and revealed that MxiCFL elutes at a volume less
than that of a monomer, but greater than that of a
dimer (Fig. 1a). This result, combined with dynamic
light-scattering data that revealed a major speciesfractions containing MxiC were further purified by size-
exclusion chromatography as described above. SDS-PAGE
analysis revealed MxiCFL and MxiCNΔ73 to be pure (data
not shown). Fractions containing purified MxiC were
pooled and concentrated using Millipore Ultra-15 10 k
MWCO centrifugal filtration devices to 7 mg ml−1 and
stored at 4 °C. Selenomethionine (SeMet)-labeledMxiCwas
produced by expression in the E.coli met− auxotrophic strain
B834 (DE3). Cultures were grown in LB medium to an
A600 nm of 0.9 then pelleted (15 min, 4000g, 4 °C) and
washed in PBS three times before being used to inoculate
SelenoMet Medium Base™ containing SelenoMet Nutrient
Mix™ (Molecular Dimensions). Cells were grown and
induced as described above. SeMet-labeled protein was
purified as described above. Full incorporation of seleno-
methioninewas confirmed bymass spectrometry. Dynamic
light-scattering experiments were performed on a Viscotek
model 802 DLS instrument using the OmniSIZE 2.0
acquisition and control software according to the manufac-
turer's instructions at 20 °C on a 1 mg ml−1 protein sample
in 20 mM Tris (pH 7.5), 150 mM NaCl.
987MxiC Structures Differ from the Yersinia Homologuewith a larger than expected hydrodynamic radius
(Rh ∼3.8 nm), suggested that MxiCFL does not
possess a globular structure and may possess an
elongated fold and/or be partially disordered. In
crystallization trials, MxiCFL initially yielded three
different crystal forms (two distinct P21 and one
P43212) that diffracted only to 3.5–3.9 Å resolution.
Selenomethionine-labeled MxiCFL yielded crystals
(P43212 with a different cell) that diffracted to 3.2 Å
resolution and were used for phasing by the
multiple-wavelength anomalous diffraction (MAD)
method (Table 1). Preliminary model building into
these maps revealed that the first 70–80 residues
were poorly ordered and not visible in the electron
density. In addition,weobserved that, in solution, the
N terminus was susceptible to proteolytic degrada-
tion (Fig. 1b). Limited proteolysis with subtilisin
followed by N-terminal sequencing and mass spec-
trometry revealed several degradation products
resulting from cleavage of the N terminus up to
residue 64. This proteolytically sensitive region of
MxiC is equivalent to the region of YopN (32–76) that
was shown to bind its chaperone andwas disordered
in the absence of this chaperone.5 Furthermore,
in vivo, the stable expression and efficient secretion
of YopN requires its chaperone.18 The proteolytic
susceptibility of the N-terminal region of MxiC
suggests that chaperone binding may act to protect
MxiC from degradation via a similar mechanism. To
date, a chaperone for MxiC has not been identified.
In order to improve the quality of MxiC crystals, a
shortened construct encompassing residues 74–355
(MxiCNΔ73) was expressed, purified (Fig. 1a) and
subjected to crystallization trials.
The structure of MxiC
Reductivemethylation ofMxiCNΔ73 yielded crystals
that diffracted to higher resolution: 2.85 Å and 2.5 Å in
space groups P212121 and P222, respectively (Table 1).
MxiC is an elongated rod-shapedmoleculewith a long
axis of 86Å (Fig. 2a). It is composed of three domains,
each possessing a four-helix X-bundle fold (Fig.
2b).19 The first and last domains consist only of the X-
bundlemotif while the central domain also possesses
a bent helix (α5) that is packed against domain 1. It is
the first two domains of MxiC that are equivalent to
YopN while the third domain of MxiC, equivalent to
TyeA, is connected to domain 2 via a ten-residue
linker. This linker acts only to tether the domains and
does not have anymajor structural role, allowing the
equivalent regions of MxiC and YopN–TyeA to
adopt similar folds. There are a total of seven
independent MxiC molecules in the crystallographic
asymmetric units of the three refined crystal forms
(see Table 1). These structures reveal that, although
the fold of each domain is maintained in all
structures (rmsd over Cα atoms of domains 1, 2
and 3 are 0.5 Å, 0.9 Å and 0.8 Å, respectively), there is
some flexibility at the interfaces between domains
resulting in a “wobble” of the terminal domains
about the central domain (rmsd over all Cα atoms of
1.4 Å; Fig. 2c). The elongated shape of MxiC meansthat the most distal regions undergo the greatest
displacement while the more central interdomain
interfaces undergo minimal change.
The structural similarity between the domains of
MxiC suggests that they might be the product of
gene duplication events. Such internal repetition
arising via intragenic duplication and recombina-
tion events has been a successful stratagem through-
out evolution for enlargement of the available
surface area.20 This, combined with the elongated
shape of MxiC, provides the maximal exposure of
surface area and considerable binding interfaces
suitable for large substrates, linear peptides or
multiple partners. This feature is typical of scaffold-
ing proteins that act to recruit multiple proteins and
enhance signaling.21,22
Pallen et al. used multiple sequence alignments to
identify members of the MxiC/YopN–TyeA family
from divergent Gram-negative species;7 a structure-
based sequence alignment of MxiC and YopN–TyeA
(Fig. 3a) differs in the N-terminal region from the
alignment obtained in that work, and highlights the
need to be cautious when interpreting conservation
based on sequence alignments alone. The combina-
tion of structural and sequence alignment informa-
tion identifies that most of the highly conserved
residues are involved in maintaining the correct fold
of these proteins. In support of this, mutations of
YopN that constitutively block secretion replace
highly conserved residues that are buried in the
interfaces between domains of YopN.23 Ferracci et al.
suggested that these mutations are likely to cause
part of YopN to become unfolded or less well-
ordered.23 Interestingly, mapping of sequence con-
servation onto the structure across the more closely
related Salmonella, Burkholderia and Shigella species
reveals a hydrophobic patch on the surface of the
central domain consisting of residues Leu222,
Met226, Gly239, Leu242 and Leu245 (Fig. 3b, red
circle). This region is buried by crystal contacts in all
seven independent molecules of MxiC in the
P212121, P222 and P43212 crystal forms, suggesting
that this region may be a “hot spot” for protein–
protein interactions.
A structural homology search using the DALI
algorithm,24 and the Secondary Structure Matching
algorithm of MSDfold,25 was unable to identify any
protein, other than YopN, possessing multiple X-
bundle motifs. However, two classes of proteins were
identified that possess X-bundle motifs similar to the
individual domains of MxiC. The structural homo-
logues belonged to the Bcl-2 family of apoptosis
regulators, specifically the Caenorhabditis elegans
homologue Ced9 (DALI Z-score 4.3, 1ohu)26 and
the programmed cell death proteins involved in
inhibition of protein synthesis, specifically the MA3
domain of Pdcd4 (DALI Z-score 3.9, 2nsz).27 Al-
though the significance of these similarities is un-
certain, structural mimicry of apoptotic factors is a
common theme seen in viral and bacterial pathogens
and represents an important defense against the host
immune response.28,29 This structural similarity may
be of functional relevance, as MxiC has been iden-
Table 1. Statistics for crystallographic data collection and structure refinement (values in parentheses are for the highest resolution shell)
MxiCNΔ73 methylated MxiCNΔ73 methylated MxiCFL MxiCFL SeMet
A. Data collection Peak Inflexion Rm1 Rm2
No. crystals used 1 1 1 1
X-ray source ESRF ID29 Diamond I03 ESRF ID29 ESRF ID29
Detector ADSC CCD scanner ADSC CCD scanner ADSC CCD scanner ADSC CCD scanner
Wavelength (Å) 0.9756 0.9757 0.9760 0.9799 0.9801 1.033 0.9756
Space group (Z) P222 (8) P212121 (12) P43212 (16) P43212 (8)
Unit-cell dimensions
a (Å) 83.48 89.31 91.37 85.54
b (Å) 83.45 102.97 91.37 85.54
c (Å) 117.07 123.57 215.84 118.2
Resolution limits (Å) 42.0–2.5 (2.64–2.50) 50.4–2.85 (3.00–2.85) 38.6–3.0 (3.16–3.00) 33.0–3.5 (3.69–3.50) 30.3–3.6 (3.79–3.60) 30.3–3.6 (3.79–3.60) 32.22–3.7 (3.90–3.70)
Measured reflections 100,493 (14,918) 84,697 (9,365) 129,136 (18,976) 49,227 (7385) 69,519 (10,267) 69,324 (10,270) 42,578 (6366)
Unique reflections 28,754 (4173) 26,409 (3546) 18,797 (2675) 5964 (848) 5539 (773) 5525 (773) 4982 (714)
Completeness (%) 99.4 (99.9) 98.6 (93.3) 98.5 (98.4) 99.9 (99.9) 99.6 (99.9) 99.8 (99.9) 98.3 (99.3)
Multiplicity 3.5 (3.6) 3.2 (2.6) 6.9 (7.1) 8.3 (8.7) 12.6 (13.3) 12.5 (13.3) 8.5 (8.9)
Rmerge 0.068 (0.518) 0.112 (0.490) 0.072 (0.434) 0.136 (0.453) 0.135 (0.526) 0.142 (0.533) 0.140 (0.487)
Rpim 0.035 (0.269) 0.060 (0.283) 0.027 (0.164) 0.047 (0.153) 0.039 (0.144) 0.040 (0.145) 0.047 (0.160)
Average I/σ(I) 14.2 (2.7) 10.7 (2.4) 14.0 (4.5) 17.5 (4.9) 20.3 (5.3) 20.4 (5.4) 16.3(4.5)
Wilson B-value (Å2) 59.3 65.5 171 79.5 59.0 55.3 62.7
B. Refinement C. MAD Phasing statistics
Resolution Range (Å) 42.0–2.5 (2.65–2.50) 50.4–2.85 (3.00–2.85) 38.6–3.0 (3.18–3.0) SHARP FOMacentrics: 0.945 (32–14 Å); 0.491 (32–3.5 Å); 0.174 (3.6–3.5 Å)
Working set reflections 23,449 (3,933) 25,054 (3,693) 17,728 (2,762) SHARP FOMcentrics: 0.789 (32–14 Å); 0.395 (32–3.5 Å); 0.127 (3.6–3.5 Å)
Free set reflections 1259 (217) 1314 (211) 1014 (154)
R 0.211 (0.237) 0.244 (0.245) 0.246 (0.306) SHARP phasing power (iso/ano):
Rfree 0.265 (0.278) 0.273 (0.295) 0.270 (0.375) Peak: (-)/1.3; Inflexion: 1.3/0.1; Rm1:0.4/0.9;Rm2:0.3/0.6
Residues A/B:64-355 A:73-355 A/B:73-355 Solvent flattened FOMoverall: 0.897 (32–8 Å); 0.870 (32–3.5 Å); 0.799 (3.6–3.5 Å)
B:73-355
C:72-352
Protein atoms 4776 6967 4750
Water molecules 191 135 13
r.m.s.d. from ideal
Bond lengths (Å) 0.006 0.006 0.005
Bond angles (deg.) 0.935 0.821 0.773
Mean protein B-factor (Å2) 62.8 60.0 140
Ramachandran plot (non-Gly
and Pro), residues in
Favored regions (%) 94.4 95.8 92.2
Allowed regions (%) 97.6 99.5 98.4
PDB ID 2VJ4 2VIX 2VJ5
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tion-quality crystals of SeMet-labeled MxiCFL†. Crystals of
native MxiCFL diffracting to 3.0 Å resolution grew in 0.2 M
Na2SO4, 0.1 M BisTris–propane (pH 6.5), 20% (w/v)
PEG3350, again in P43212 but with a longer c axis and two
molecules in the asymmetric unit. The methylation re-
action was performed as described in Refs. 31 and 32 on
purified MxiCFL and MxiCNΔ73 each at 1 mg ml
−1 in
50 mM Hepes (pH 7.5), 250 mM NaCl. Samples were
centrifuged (5 min, 13,000 rpm, 10,000g 4 °C) before
989MxiC Structures Differ from the Yersinia Homologuetified as a protein that is secreted by the T3SS under
conditions that mimic those encountered by bacteria
during infection of a host.3
Comparison with the YopN–TyeA complex
Although the individual domains of MxiC and
YopN–TyeA adopt similar folds (rmsd over CαFig. 2. The structure and topology of MxiC. a, A ribbon
diagram of MxiC, colored from blue at the N terminus to
red at the C terminus. Views rotated by 90° about the long
axis are shown. b, A diagram of the topology of MxiC
illustrating the four-helix X-bundle of each domain
colored as for a. c, Two molecules of MxiC from the
P212121 crystal form (molecule B in magenta and molecule
C in cyan), overlaid via their central domain (residues
154–265), illustrating the extremes of the movement seen
for domains 1 and 3 (shown with cylindrical helices).
Methods: Initial crystallization conditions were obtained
by sparse-matrix screening,30 using the sitting drop vapor
diffusion technique. Drops were prepared using an
OryxNano crystallization robot (Douglas Instruments)
by mixing 0.2 μl of protein (7 mg ml−1 in 20 mM Tris (pH
7.5), 150 mM NaCl) with 0.2 μl of reservoir solution and
were equilibrated against 100 μl of reservoir solution at
20 °C. Initial, low-resolution diffracting crystals of MxiCFL
grew within two weeks in condition P2-26 of the PACT
Premier screen (0.2 M NaBr, 0.1 M BisTris–propane (pH
7.5), 20% (w/v) PEG3350: space group P43212 with one
molecule in the asymmetric unit) and condition 3 of
Molecular Dimensions Structure Screen II (2% (v/v)
dioxane, 0.1 M bicine (pH 9.0), 10% (w/v) PEG20000:
two different, related P21 forms with two molecules in the
asymmetric unit). The former condition yielded diffrac-
purification of soluble methylated protein by size-exclu-
sion chromatography (as described above). Methylation of
all lysine side chains and the N terminus was verified by
mass spectrometry (42,952 Da for MxiCFL and 35,106 Da
for MxiCNΔ73). The P222 crystal form grew in 1.0 M
succinic acid, 0.1 M Hepes (pH 7.0), 1% (w/v)
PEG2000MME. The P212121 crystal form grew in 0.2 M
sodium acetate, 0.1 M BisTris–propane (pH 7.5), 20%
(w/v) PEG3350. Crystals of MxiC were cryoprotected in
reservoir solution containing 25% (v/v) glycerol for 15 s
and flash cryocooled in liquid nitrogen for data
collection. Diffraction data were recorded at 100 K.
Data were indexed and integrated in MOSFLM,33 and
scaled with Scala,34 within the CCP4 program suite,35
except for the native MxiCFL P43212 3.0 Å dataset,
which was indexed in Labelit36 and integrated in XDS,37
both run from the processing suite Xia2 (G. Winter et al.,
unpublished program). Initial phases were computed using
SHARP:38 five sites were found by SHELXD39 run from the
suite of programs autoSHARP40 against FAs calculated from
the peak, inflexion and low-energy remotewavelengths of a
SeMet-labeled P43212 MxiCFL crystal. The coordinates and
B-factors of these sites were refined in SHARP against the
above data plus the second remote wavelength from the
same SeMet crystal. Solvent flatteningwas performed using
CCP4-DM41 and SOLOMON,42 yielding a 3.5 Å map that
was used for initial model building guided by the YopN–
TyeA structure (PDB ID 1xl3).5 After alternate cycles of
model building in Coot,43 refinement in Buster-TNT,44 and
simulated annealing in PHENIX,45 this initial model was
used for molecular replacement, using CCP4 PHASER,46
into the higher resolutionP212121 form. The resultantmodel
was used for molecular replacement against the MxiCNΔ73
P222 and native MxiCFL P43212 crystal forms. The final
Buster-TNT refinements in the latter forms used NCS
restraints throughout, and extra geometry restraints tying
the geometry to Refmac47-refined models, to improve the
stereochemistry (as Refmac5 implements torsion angle
restraints and can refine riding H atoms), a refinement
strategy devised by Dr. Stephen Graham (University of
Oxford).atoms of the first and second domains of MxiC
with the equivalent regions of YopN of 3.9 Å and
3.2 Å, respectively, and the third domain of MxiC
with TyeA of 0.8 Å), the arrangement of these
domains results in a different overall shape for these
molecules (Fig. 3b). This structural rearrangement
differs from the “wobble” seen between different
MxiC molecules and is particularly noticeable in one
orientation (Fig. 3b, top panel). This view highlights
the straight conformation adopted by MxiC and
the relative curvature of the YopN–TyeA complex.†Neither the structures of the crystal forms diffracting
at low resolution nor the SeMet P43212 form were fully
refined nor are reported in Table 1.
Fig. 3. Comparison of MxiC with the YopN–TyeA complex. a, Structure-based sequence alignment of MxiC and
YopN–TyeA. The positions of helices for each protein are illustrated (cylinders) above and below the sequence. b, Ribbon
diagrams of MxiC (green) and YopN (cyan) complexed with TyeA (yellow). Helix α9 of MxiC and the equivalent helix of
YopN are shown as cylinders. Two orientations rotated by 90° about the long axis are shown. The conserved hydrophobic
patch onMxiC consisting of residues Leu222, Met226, Gly239, Leu242 and Leu245 is circled in red. c, Electrostatic surfaces
of MxiC (left) and YopN-TyeA (right) are shown in the same orientation as in b (lower panel). Electrostatic surfaces were
calculated using the APBS48 plugin of PyMol [http://www.pymol.org] with default settings. The electrostatic potential is
displayed on the molecular surface and plotted in a red-white-blue scale (red, negative; blue, positive).
990 MxiC Structures Differ from the Yersinia HomologueThe different position and orientation of the first
domain of MxiC may be due, in part, to the missing
N-terminal portion, as the YopN–TyeA structure
possesses an additional helix at its N terminus.
It seemed likely that the major difference between
these structures would be the arrangement of the
domain equivalent to TyeA as this is a separatepolypeptide in the Yersinia structure. Surprisingly,
themost striking difference instead involves the long
á-helix (α9) in the central domain of MxiC, which is
straight in all of our MxiC structures, but possesses a
sharp kink in YopN when complexed with TyeA
(Fig. 3b). It is the straightening of this helix that
results in a reorientation of the C-terminal domain of
991MxiC Structures Differ from the Yersinia HomologueMxiC, compared with TyeA, and opens one face of
the molecule. As the sequence at the hinge is not
conserved, and all MxiC molecules possess the
straight helix conformation, these structures may
represent genuine differences between species. Alter-
natively, it may represent a conformational switch
that, in this case, was captured due to the very
different pH for the YopN–TyeA structure (pH 10.5)
compared with the MxiC structures (pH 6.5–7.5).
Despite the lack of sequence conservation on the
surface of these structures, an analysis of the surface
electrostatics reveals that the face that is curved in
YopN–TyeA and open in MxiC possesses a con-
served negatively charged patch (Fig. 3c). This patch
spreads across one face of the C-terminal half of the
molecule (displayed in red on the right-hand side of
the surface shown in Fig. 3c). The helices that line
this face undergo minor repacking and can accom-
modate the large movements of the surrounding
domains. The conserved patch on this face suggests
a role for this region in interactions with partner
proteins. If this is a binding face for another
component of the T3SS, it is interesting to note
that this interface is conserved despite it being intra-
molecular in one homologue and intermolecular in
another.
Protein Data Bank accession numbers
The atomic coordinates and structure factors have
been deposited at the RCSB Protein Data Bank with
accession codes 2vix (P212121), 2vj4 (P222) and 2vj5
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